The Biobanking Market is predicted to reach US$ ~98.1 billion by 2030 from US$ ~66.6 billion in 2021, and to grow at a CAGR of ~4.4% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Products
Products & Services (Equipment, Consumable, Software and Services), Sample Type (Blood products, Cell Lines, Human Tissues, Biological Fluids, Nucleic Acids and others) Application (Regenerative Medicine, Life Science, Clinical Research) Storage Type (Manual Storage and Automated Storage)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Thermo Fisher Scientific Inc., BD, PHC Corporation., QIAGEN, VWR International, LLC., Hamilton Company, Tecan Trading AG, Brooks Life Sciences, Greiner Bio-One International GmbH, Promega Corporation, among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Biobanking Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Biobanking Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Biobanking Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Biobanking Market - ANALYSIS & FORECAST, BY REGION
North America Biobanking Market
1. North America Biobanking Market, by Country
1. US
2. Canada
1. North America Biobanking Market, by Product
2. North America Biobanking Market, by Type
3. North America Biobanking Market, by Gender
4. North America Biobanking Market, by Sales Channel
3. Europe Biobanking Market
1. Europe Biobanking Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Biobanking Market, by Product
3. Europe Biobanking Market, by Type
4. Europe Biobanking Market, by Gender
5. Europe Biobanking Market, by Sales Channel
4. Asia Pacific Biobanking Market
1. Asia Pacific Biobanking Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Biobanking Market, by product
3. Asia Pacific Biobanking Market, by Type
4. Asia Pacific Biobanking Market, by Gender
5. Asia Pacific Biobanking Market, by Sales Channel
5. Rest of the World Biobanking Market
1. Rest of the World Biobanking Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Biobanking Market, by Product
3. Rest of the World Biobanking Market, by Type
4. Rest of the World Biobanking Market, by Gender
5. Rest of the World Biobanking Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 8
Price : US$ 3500 |
Date : Sep 2023 |
Category : Services |
Pages : 163 |